Clinical Trial Update: Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis [Phase 3]

View source ↗

Summary

Phase III randomized study of inhaled tobramycin in cystic fibrosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TOBI (Tobramycin inhalation solution)
• Tobramycin Inhalation Solution (tobramycin inhalation solution)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Cystic Fibrosis, Bacterial Infection | Phase 3 | Status: COMPLETED